The average Chinese person now accounts for more carbon emissions annually than the average European
The latest Ferrari glitch may or may not be a flaw, depending on how often you plan to use your $234,000 sports car in kidnappings
NASA's decision to hire both Boeing and SpaceX to design and build new space shuttles illustrates a debate in government contracting as to how many suppliers is best
The photo agency is increasingly making its work available to customers without a licensing fee, with the plan to develop a business model at some point in the future
The popular premixed funds are supposed to get more conservative as retirement gets closer. What “conservative” means is open to interpretation
Airbus has reduced the width of a bathroom on the new A320s to restore space in the food-preparation area
Has anyone enjoyed being a CEO more than Oracle's sort-of outgoing Larry Ellison?
Business students at Wharton reveled in a ritual gathering of MBAs where people leave their personal brand at the door
Evan Thornley, Australian multimillionaire and co-founder of online advertising company LookSmart, has since apologized
San Mateo, Calif.
Founders: Dr. Michael Selley, Dr. Lawrence Steinman, and Dr. Marc Feldmann
VC Investment over the last four quarters: $27 million
Founded in Australia in 2005 and established in the U.S. in 2007, Nuon Therapeutics is a clinical stage company developing oral treatments for multiple sclerosis and rheumatoid arthritis. The six-employee firm, which had previously raised a $5 million Series A round, is continuing development while conserving cash during the downturn, says CEO Rodney Pearlman. "Since we are in clinical stage development, this can be an expensive phase, so we have to ensure we meet our goals while being fiscally responsive to the current environment," he says.
Key to startup success: "Be opportunistic and think outside the box."